You are here



This is the first time a public company in Catalonia has manufactured advanced cell therapy drugs, which allow for the regeneration of injured or degenerated tissues.


According to 'Catalonia Life Sciences Report' presented by Ernst&Young and Biocat under the framework of the BIO International Convention in Boston (USA).


Experts from Catalonia and Valencia forecast that the future will rely on expertise, on researchers’ ability to address real needs and on public/private collaboration systems to compete with countries like China.


The hospital presents a new data-entry and group-work platform for virtual communities in the biomedical arena, which optimizes time and costs.


This drug could begin to be applied as of 2013 in patients that currently have no therapeutic alternatives.


Félix Delgado Bocos Foundation, chaired by John de Zulueta, announces a contest to promote the modernization of health systems.


The laboratory can process up to ten samples, extracted after birth, per day. Samples are stored in banks in Germany and Poland.


This practical course on cell biology aims to improve science teaching in secondary schools in the Barcelona area.


The '2011 Biocat Report: Portrait of a sector in motion' was presented before some 150 politicians, businesspeople and professionals from the sector.


Minister Andreu Mas-Colell will preside over the act, to be held 27 October at Barcelona’s Palau Robert.